Kenneth Galbraith, Chair & CEO at Zymeworks Inc. (ZYME), sold 95,056 shares at $27.02 ($2.6M) on 2025-12-22, disclosed to the SEC on 2025-12-22.
Open-market sale of $2.6M ZYME by Chair & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.02 | 47,528 | $1.3M | 50.0% |
| 2 | $27.02 | 47,528 | $1.3M | 50.0% |
| Total | $27.02 avg | 95,056 | $2.6M | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $1.7M | — | Filing → |
| ZYME | SELL | 2024-01-08 | $516K | — | Filing → |
| MGNX | SELL | 2020-09-10 | $1.1M | — | Filing → |